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The US Renal Data System (USRDS) is the largest and most comprehensive national end-
stage renal disease (ESRD) and chronic kidney disease (CKD) surveillance system in the 
world. Supported by the Centers for Medicare & Medicaid Services and the National 
Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes 
of Health, the USRDS Coordinating Center is operated by the University of Michigan at the 
Kidney Epidemiology and Cost Center (KECC), in partnership with Arbor Research 
Collaborative for Health, in Ann Arbor, Michigan.
Trends in the prevalence of CKD and ESRD are important for health care policy and 
planning. The prevalence of earlier stages of CKD, while relatively stable at 14.8%, implies 
that an estimated 30 million American adults have CKD, with millions of others at increased 
risk. In 2015, there were 124,111 new cases of ESRD reported, with a total of nearly 
500,000 patients receiving maintenance dialysis treatments and well over 200,000 living 
with a kidney transplant.
The cost to care for patients with CKD remains significant. In 2015, for Medicare 
beneficiaries with kidney disease alone, the total spending was nearly $100 billion. This 
included over $64 billion in spending for all Medicare beneficiaries who have CKD and 
another $34 billion for beneficiaries with ESRD.
In sharp contrast to the high burden and cost is the low awareness about the condition among 
patients with kidney disease, especially those in CKD Stages 1 to 3.
Noteworthy was the decline of approximately 41.6% in the 1-year ESRD patient mortality 
among the 0- to 4-year-old age group over the past decade. Also noted for the first time was 
a decrease in the kidney transplant waiting list, by 2.3%. This is likely a result of recent 
changes in the kidney allocation system.
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We hope researchers, practitioners, and policy makers will gain valuable insights by fully 
exploring these and many other patterns of US kidney disease in this year’s USRDS annual 
report.
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